Copyright Reports & Markets. All rights reserved.

Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Report 2021

Request for Sample of this report
Buy now

1 Gonadotropin-releasing Hormone Agonist Drugs Market Overview

  • 1.1 Gonadotropin-releasing Hormone Agonist Drugs Product Scope
  • 1.2 Gonadotropin-releasing Hormone Agonist Drugs Segment by Type
    • 1.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Leuprorelin
    • 1.2.3 Goserelin
    • 1.2.4 Taltirelin
    • 1.2.5 Histrelin
    • 1.2.6 Other
  • 1.3 Gonadotropin-releasing Hormone Agonist Drugs Segment by Application
    • 1.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Hospital
    • 1.3.3 Pharmacy
    • 1.3.4 Other
  • 1.4 Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price Trends (2016-2027)

2 Gonadotropin-releasing Hormone Agonist Drugs Estimates and Forecasts by Region

  • 2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Region (2016-2021)
  • 2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2016-2027)
    • 2.4.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2016-2027)
    • 2.4.3 China Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2016-2027)
    • 2.4.4 Japan Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2016-2027)
    • 2.4.6 India Gonadotropin-releasing Hormone Agonist Drugs Estimates and Projections (2016-2027)

3 Global Gonadotropin-releasing Hormone Agonist Drugs Competition Landscape by Players

  • 3.1 Global Top Gonadotropin-releasing Hormone Agonist Drugs Players by Sales (2016-2021)
  • 3.2 Global Top Gonadotropin-releasing Hormone Agonist Drugs Players by Revenue (2016-2021)
  • 3.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gonadotropin-releasing Hormone Agonist Drugs as of 2020)
  • 3.4 Global Gonadotropin-releasing Hormone Agonist Drugs Average Price by Company (2016-2021)
  • 3.5 Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Type

  • 4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Type (2016-2021)
  • 4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price Forecast by Type (2022-2027)

5 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Application

  • 5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price by Application (2016-2021)
  • 5.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Price Forecast by Application (2022-2027)

6 North America Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures

  • 6.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Company
    • 6.1.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Company (2016-2021)
    • 6.1.2 North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Company (2016-2021)
  • 6.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type
    • 6.2.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2022-2027)
  • 6.3 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application
    • 6.3.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application (2022-2027)

7 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures

  • 7.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Company
    • 7.1.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Company (2016-2021)
    • 7.1.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Company (2016-2021)
  • 7.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type
    • 7.2.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application
    • 7.3.1 Europe 130 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 130 Sales Breakdown by Application (2022-2027)

8 China Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures

  • 8.1 China Gonadotropin-releasing Hormone Agonist Drugs Sales by Company
    • 8.1.1 China Gonadotropin-releasing Hormone Agonist Drugs Sales by Company (2016-2021)
    • 8.1.2 China Gonadotropin-releasing Hormone Agonist Drugs Revenue by Company (2016-2021)
  • 8.2 China Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type
    • 8.2.1 China Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2022-2027)
  • 8.3 China Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application
    • 8.3.1 China 243 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 243 Sales Breakdown by Application (2022-2027)

9 Japan Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures

  • 9.1 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales by Company
    • 9.1.1 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales by Company (2016-2021)
    • 9.1.2 Japan Gonadotropin-releasing Hormone Agonist Drugs Revenue by Company (2016-2021)
  • 9.2 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type
    • 9.2.1 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application
    • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures

  • 10.1 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales by Company
    • 10.1.1 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type
    • 10.2.1 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Gonadotropin-releasing Hormone Agonist Drugs Market Facts & Figures

  • 11.1 India Gonadotropin-releasing Hormone Agonist Drugs Sales by Company
    • 11.1.1 India Gonadotropin-releasing Hormone Agonist Drugs Sales by Company (2016-2021)
    • 11.1.2 India Gonadotropin-releasing Hormone Agonist Drugs Revenue by Company (2016-2021)
  • 11.2 India Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type
    • 11.2.1 India Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Type (2022-2027)
  • 11.3 India Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application
    • 11.3.1 India Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Gonadotropin-releasing Hormone Agonist Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Gonadotropin-releasing Hormone Agonist Drugs Business

  • 12.1 AbbVie
    • 12.1.1 AbbVie Corporation Information
    • 12.1.2 AbbVie Business Overview
    • 12.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.1.5 AbbVie Recent Development
  • 12.2 AstraZeneca
    • 12.2.1 AstraZeneca Corporation Information
    • 12.2.2 AstraZeneca Business Overview
    • 12.2.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.2.5 AstraZeneca Recent Development
  • 12.3 Ferring
    • 12.3.1 Ferring Corporation Information
    • 12.3.2 Ferring Business Overview
    • 12.3.3 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Ferring Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.3.5 Ferring Recent Development
  • 12.4 TerSera Therapeutics
    • 12.4.1 TerSera Therapeutics Corporation Information
    • 12.4.2 TerSera Therapeutics Business Overview
    • 12.4.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.4.5 TerSera Therapeutics Recent Development
  • 12.5 Takeda
    • 12.5.1 Takeda Corporation Information
    • 12.5.2 Takeda Business Overview
    • 12.5.3 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Takeda Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.5.5 Takeda Recent Development
  • 12.6 LIVZON
    • 12.6.1 LIVZON Corporation Information
    • 12.6.2 LIVZON Business Overview
    • 12.6.3 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.6.5 LIVZON Recent Development
  • 12.7 Ipsen
    • 12.7.1 Ipsen Corporation Information
    • 12.7.2 Ipsen Business Overview
    • 12.7.3 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.7.5 Ipsen Recent Development
  • 12.8 Sanofi
    • 12.8.1 Sanofi Corporation Information
    • 12.8.2 Sanofi Business Overview
    • 12.8.3 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.8.5 Sanofi Recent Development
  • 12.9 Endo
    • 12.9.1 Endo Corporation Information
    • 12.9.2 Endo Business Overview
    • 12.9.3 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Endo Gonadotropin-releasing Hormone Agonist Drugs Products Offered
    • 12.9.5 Endo Recent Development

13 Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Cost Analysis

  • 13.1 Gonadotropin-releasing Hormone Agonist Drugs Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Gonadotropin-releasing Hormone Agonist Drugs
  • 13.4 Gonadotropin-releasing Hormone Agonist Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Gonadotropin-releasing Hormone Agonist Drugs Distributors List
  • 14.3 Gonadotropin-releasing Hormone Agonist Drugs Customers

15 Market Dynamics

  • 15.1 Gonadotropin-releasing Hormone Agonist Drugs Market Trends
  • 15.2 Gonadotropin-releasing Hormone Agonist Drugs Drivers
  • 15.3 Gonadotropin-releasing Hormone Agonist Drugs Market Challenges
  • 15.4 Gonadotropin-releasing Hormone Agonist Drugs Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global Gonadotropin-releasing Hormone Agonist Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gonadotropin-releasing Hormone Agonist Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Leuprorelin
    Goserelin
    Taltirelin
    Histrelin
    Other

    Segment by Application
    Hospital
    Pharmacy
    Other

    The Gonadotropin-releasing Hormone Agonist Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Gonadotropin-releasing Hormone Agonist Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    AbbVie
    AstraZeneca
    Ferring
    TerSera Therapeutics
    Takeda
    LIVZON
    Ipsen
    Sanofi
    Endo

    Buy now